Related Experiment Video
Updated: Dec 21, 2025
06:35
Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
Published on: April 27, 2016
18.5K
Correction to: The International/Canadian Hereditary Angioedema Guideline
Stephen Betschel1, Jacquie Badiou2, Karen Binkley1
11University of Toronto, Toronto, ON Canada.
Insights
This study corrects a previous article DOI. The corrected DOI is 10.1186/s13223-019-0376-8 for accurate citation and retrieval.
Area of Science:
- Bibliometrics and Scientific Communication
Context:
- Ensuring accurate citation is crucial for scientific integrity.
- Digital Object Identifiers (DOIs) are essential for locating research articles.
Purpose:
- To provide a correction for an incorrect article DOI.
- To facilitate proper referencing and access to the intended research.
Summary:
- This entry serves as a correction notice for a previously published article.
- The correct Digital Object Identifier (DOI) is provided to ensure accurate referencing.
Impact:
- Improves the reliability of scientific literature databases.
- Facilitates seamless access to research for the scientific community.
- Upholds scholarly communication standards.
Abstract:
[This corrects the article DOI: 10.1186/s13223-019-0376-8.].
Related Concept Videos
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
3.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.9K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
807
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
807
01:29Cardiomyopathy V: Interprofessional Care
219
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
219
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.1K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.1K
01:26Aneurysm III: Interprofessional Care
182
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
182
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.2K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.2K